We are live on ! Find out more
AACP

Advantage Alpha Capital Partners Portfolio holdings

AUM $332M
1-Year Est. Return 12.78%
This Fund
S&P 500
This Quarter Est. Return
+8.8%
1 Year Est. Return
+12.78%
3 Year Est. Return
+79.23%
5 Year Est. Return
+110.24%
10 Year Est. Return
–
AUM
$332M
AUM Growth
-$39.1M
Cap. Flow
-$62.1M
Cap. Flow %
-18.72%
Top 10 Hldgs %
18.07%
Holding
140
New
21
Increased
26
Reduced
83
Closed
10

Top Buys

Rank Stock Value
1
HROW icon
Harrow
HROW
+$4.2M
2
TRNS icon
Transcat
TRNS
+$3.76M
3
RHP icon
Ryman Hospitality Properties
RHP
+$3.16M
4
UTI icon
Universal Technical Institute
UTI
+$3M
5
WAY
Waystar Holding Corp
WAY
+$2.93M

Top Sells

Rank Stock Value
1
CECO icon
Ceco Environmental
CECO
+$6.18M
2
SN icon
SharkNinja
SN
+$4.32M
3
WK icon
Workiva
WK
+$4.31M
4
MGNI icon
Magnite
MGNI
+$4.3M
5
FTAI icon
FTAI Aviation
FTAI
+$4.01M

Sector Composition

Rank Sector Weight
1 Industrials 35.84%
2 Technology 18.8%
3 Healthcare 15.52%
4 Consumer Discretionary 10.94%
5 Financials 7.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RIOT icon
101
Riot Platforms
RIOT
$7.08B
$647K 0.19%
33,990
-6,912
-17% -$95.7K
HALO icon
102
Halozyme
HALO
$11.9B
$621K 0.19%
8,466
-1,567
-16% -$104K
ANIP icon
103
ANI Pharmaceuticals
ANIP
$1.68B
$582K 0.18%
6,354
-1,598
-20% -$130K
VCYT icon
104
Veracyte
VCYT
$3.51B
$544K 0.16%
15,859
-3,264
-17% -$93.6K
ADMA icon
105
ADMA Biologics
ADMA
$2.11B
$498K 0.15%
33,943
-9,875
-23% -$169K
CLSK icon
106
CleanSpark
CLSK
$2.98B
$434K 0.13%
29,926
-6,827
-19% -$77K
ALKS icon
107
Alkermes
ALKS
$7.99B
$424K 0.13%
14,122
-3,200
-18% -$90.2K
KRYS icon
108
Krystal Biotech
KRYS
$10.4B
$421K 0.13%
2,387
-507
-18% -$75.9K
TGTX icon
109
TG Therapeutics
TGTX
$8.33B
$419K 0.13%
11,598
-2,716
-19% -$89.5K
ARWR icon
110
Arrowhead Research
ARWR
$12B
$406K 0.12%
11,780
-1,158
-9% -$25.5K
EBS icon
111
Emergent Biosolutions
EBS
$305M
$405K 0.12%
+45,936
New +$357K
STOK icon
112
Stoke Therapeutics
STOK
$2.06B
$398K 0.12%
16,941
-947
-5% -$16.2K
MDXG icon
113
MiMedx Group
MDXG
$656M
$396K 0.12%
56,727
-9,397
-14% -$65.3K
PTGX icon
114
Protagonist Therapeutics
PTGX
$9.35B
$386K 0.12%
5,804
-1,168
-17% -$66.4K
KURA icon
115
Kura Oncology
KURA
$1.13B
$380K 0.11%
+42,958
New +$306K
RIGL icon
116
Rigel Pharmaceuticals
RIGL
$866M
$334K 0.1%
+11,804
New +$353K
CDNA icon
117
CareDx
CDNA
$2.59B
$308K 0.09%
+21,164
New +$302K
KROS icon
118
Keros Therapeutics
KROS
$217M
$286K 0.09%
+18,059
New +$267K
HUT
119
Hut 8
HUT
$9.77B
$275K 0.08%
+7,898
New +$201K
CPRX
120
DELISTED
Catalyst Pharmaceutical
CPRX
$262K 0.08%
13,313
-2,887
-18% -$59.4K
DVAX
121
DELISTED
Dynavax Technologies
DVAX
$257K 0.08%
25,892
-5,266
-17% -$54.8K
TBBK icon
122
The Bancorp
TBBK
$2.69B
$242K 0.07%
+3,226
New +$225K
AUPH icon
123
Aurinia Pharmaceuticals
AUPH
$2.17B
$230K 0.07%
20,849
-3,230
-13% -$35.3K
ACAD icon
124
Acadia Pharmaceuticals
ACAD
$5.02B
$227K 0.07%
10,623
-2,020
-16% -$47.8K
MARA icon
125
Marathon Digital Holdings
MARA
$4.12B
$221K 0.07%
12,094
-2,975
-20% -$50.1K
2 3 4
5
6

Similar funds

CPA
Court Place Advisors Ellicott City, Maryland $332M AUM 16.16% 1-Year Est. Return
PAWA
Palo Alto Wealth Advisors Palo Alto, California $343M AUM 33.47% 1-Year Est. Return
EE
EWG Elevate Roseville, California $320M AUM 18.11% 1-Year Est. Return
GB
Gunma Bank Gunma, Japan $319M AUM 1.17% 1-Year Est. Return
SC
Solari Capital Palm Beach Gardens, Florida $318M AUM
SFG
Sterling Financial Group Pasadena, California $316M AUM 10.54% 1-Year Est. Return
PA
Pineridge Advisors St. Charles, Missouri $350M AUM 6.38% 1-Year Est. Return
BCCM
Bridge Creek Capital Management West Barnstable, Massachusetts $360M AUM 16.27% 1-Year Est. Return

Advantage Alpha Capital Partners's Q3 2025 Portfolio in Review

As of Q3 2025, Advantage Alpha Capital Partners held 140 positions worth $332M, down 11% from $371M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Advantage Alpha Capital Partners withdrew a net $62.1M in Q3 2025, closing 10 positions and reducing 83 holdings. Its most notable exit was Boot Barn, an estimated $3.52M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 36% of assets, down from 36% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Advantage Alpha Capital Partners opened a new position in Harrow worth $5.37M.

  • Advantage Alpha Capital Partners's largest Q3 2025 buy was Harrow: 111,553 shares worth $5.37M.
  • Advantage Alpha Capital Partners added most to Casella Waste Systems in Q3 2025, an estimated $1.96M increase.
  • Advantage Alpha Capital Partners's biggest Q3 2025 reduction was Ceco Environmental, cutting an estimated $6.18M.
  • Advantage Alpha Capital Partners fully exited Boot Barn in Q3 2025, selling an estimated $3.52M.
  • Advantage Alpha Capital Partners's ten largest holdings make up 18% of its $332M portfolio in Q3 2025.
  • Advantage Alpha Capital Partners opened 21 new positions and closed 10 in Q3 2025.
  • Advantage Alpha Capital Partners's portfolio value fell 11% quarter-over-quarter to $332M.

Based on Advantage Alpha Capital Partners's 13F filing for Q3 2025, filed 12 Nov 2025.